Withholding tax obligations of Indian resident payers – practically uncertain

In their article, Phoenix Legal’s Kripi Kathuria and Ankur Verma discuss why the pharmaceutical industry in India is attracting interest from investors worldwide, noting amongst other things “ever-increasing returns, lowering risk and anticipated multifold growth”.

Corruption and the Indian infrastructure boom
Kroll’s Ramon Ghosh explains why a culture of corporate compliance is now likely to become vital when doing business in India.